Brief: TScan Therapeutics Provides Clinical Pipeline Update And Highlights Near-Term Priorities
16/04/2024 21:53
April 16 (Reuters) - TScan Therapeutics Inc TCRX.O :
* TSCAN THERAPEUTICS PROVIDES CLINICAL PIPELINE UPDATE AND
HIGHLIGHTS NEAR-TERM PRIORITIES
* TSCAN THERAPEUTICS INC -PATIENTS IDENTIFIED ACROSS ALL SIX
TCR-T
COHORTS IN SOLID TUMOR PROGRAM WITH DOSING OF FIRST THREE
EXPECTED IN EARLY MAY
* TSCAN THERAPEUTICS INC - PATIENTS IDENTIFIED ACROSS ALL
SIX
TCR-T COHORTS IN SOLID TUMOR PROGRAM WITH DOSING OF FIRST THREE
EXPECTED IN EARLY MAY
* TSCAN THERAPEUTICS INC -INITIAL DATA ON PATIENTS FROM BOTH
SINGLEPLEX AND MULTIPLEX COHORTS EXPECTED IN SECOND HALF OF 2024
Source text for Eikon: ID:nGNXbjGVx4
Further company coverage: TCRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tscan Therapeutics
See all newsU.S. RESEARCH ROUNDUP-Broadcom, Deere & Co, Snowflake
U.S. STOCKS ON THE MOVE-FuelCell, Gold miners, NetApp
U.S. STOCKS ON THE MOVE-AEVEX, Sirius XM, PG&E
U.S. STOCKS ON THE MOVE-TScan Therapeutics, EOS Energy, Brown-Forman Corp
Brief: TScan Therapeutics - Amgen To Terminate Research Collaboration And License Agreement With TScan Therapeutics - SEC Filing